Hims & Hers shares jumped nearly 50% in premarket trade on Monday after a report it has ended a dispute with Novo Nordisk by striking a partnership with the Danish drug giant.
FlashNews:
Centenary Asset Management Achieves Strongest Performance in Firm History amid Expansion of AI-Driven Investment Platform
Keyrus industrializes AI and launches the Human Orchestrated Model™ for sustainable enterprise performance
Latest Release by Ryan Tate, Letters to Tommi, Offers an Intimate Journey of Love Beyond Loss
WELOCATE FINANCE LIMITED Announces Welorix Launch of AI Solution for Automated Trading Strategy Development
Sci-Fi Meets Noir in Stephen Bramer’s Amazing New Novel, The Bonded
Ringo2number: Best Cheap Second Phone Number App 2026
How to choose a copy account on InvidiaTrade: the practical guide to put your capital to work with real criteria
Cómo elegir una cuenta copy en InvidiaTrade: la guía práctica para poner tu capital a trabajar con criterio
Slippage and requotes: the second hidden cost that decides your profitability
Slippage y requotes: el segundo costo oculto que decide tu rentabilidad
EMCD Wins World Future Awards 2026 for Best Integrated Digital Asset Ecosystem
EMCD Wins World Future Awards 2026 for Best Integrated Digital Asset Ecosystem
EMCD Wins World Future Awards 2026 for Best Integrated Digital Asset Ecosystem
EMCD Wins World Future Awards 2026 for Best Integrated Digital Asset Ecosystem
EMCD Wins World Future Awards 2026 for Best Integrated Digital Asset Ecosystem
EMCD Wins World Future Awards 2026 for Best Integrated Digital Asset Ecosystem
EMCD Wins World Future Awards 2026 for Best Integrated Digital Asset Ecosystem
EMCD Wins World Future Awards 2026 for Best Integrated Digital Asset Ecosystem
EMCD Wins World Future Awards 2026 for Best Integrated Digital Asset Ecosystem
Home » Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute